Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CorMedix Inc shares valued at $275,500 were purchased by Kaplan Myron on Oct 23 ’25. At $11.02 per share, Kaplan Myron acquired 25,000 shares. The insider’s holdings grew to 201,034 shares worth approximately $2.34 million following the completion of this transaction.
Also, DUNTON ALAN W sold 10,000 shares, netting a total of over 131,300 in proceeds. Following the sale of shares at $13.13 each, the insider now holds 40,250 shares.
Before that, Todisco Joseph had sold 50,000 shares from its account. In a trade valued at $650,000, the Chief Executive Officer traded CorMedix Inc shares for $13.00 each. Upon closing the transaction, the insider’s holdings decreased to 50,000 shares, worth approximately $5.92 million.
As published in a research note from D. Boral Capital on October 20, 2025, CorMedix Inc [CRMD] has been rated up from a Hold to a Buy and the price target has been revised to $14. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of June 30, 2025, D. Boral Capital has decreased its “Buy” rating to a “Hold” for CRMD. Earlier on March 07, 2025, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for CRMD stock.
Analyzing CRMD Stock Performance
On last trading session, CorMedix Inc [NASDAQ: CRMD] rose 2.74% to $11.62. The stock’s lowest price that day was $11.3601, but it reached a high of $11.898 in the same session. During the last five days, there has been a surge of approximately 2.74%. Over the course of the year, CorMedix Inc shares have dropped approximately -14.50%. Shares of the company reached a 52-week high of $17.43 on 06/23/25 and a 52-week low of $5.60 on 04/07/25.
Support And Resistance Levels for CorMedix Inc (CRMD)
According to the 24-hour chart, there is a support level at 11.35, which, if violated, would cause prices to drop to 11.09. In the upper region, resistance lies at 11.89. The next price resistance is at 12.16. RSI (Relative Strength Index) is 53.62 on the 14-day chart, showing neutral technical sentiment.
Is CorMedix Inc subject to short interest?
Stocks of CorMedix Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.49 million shares to 16.18 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 16.67 million shares. A decline of -3.04% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.54 of the overall float, the days-to-cover ratio (short ratio) decline to 6.54.
Which companies own the most shares of CorMedix Inc (CRMD)?
In terms of CorMedix Inc share price expectations, FactSet research, analysts set an average price target of 19.5 in the next 12 months, up nearly 72.41% from the previous closing price of $11.31. Analysts anticipate CorMedix Inc stock to reach 22 by 2025, with the lowest price target being 17. In spite of this, 2 analysts ranked CorMedix Inc stock as Buy at the end of 2025. On January 13, 2025, D. Boral Capital assigned a price target of “a Buy” to the stock and initiated coverage with a $15.
